KATHERINE SIMERSON: Open Payments
NPI 1740722479 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 26 payments from 7 companies in 2025. Trend: 2023 $496 · 2024 $879 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $245 |
| PFIZER INC. | 6 | $121 |
| ABBVIE INC. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| SK Life Science, Inc. | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: ZERBAXA, ELIQUIS, LEQVIO, JARDIANCE, DALVANCE, XIFAXAN, EMBLAVEO, TEFLARO.
Industry payments across NC — which companies pay providers there.
